Loading...
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
PURPOSE: Peptide antigens have been administered by different approaches as cancer vaccine therapy, including direct injection or pulsed onto dendritic cells; however, the optimal delivery method is still debatable. In this study, we describe the immune response elicited by two vaccine approaches us...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Springer-Verlag
2011
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3708463/ https://ncbi.nlm.nih.gov/pubmed/21927947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-011-1100-9 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|